123 related articles for article (PubMed ID: 11800644)
1. Expression of E-cadherin and p53 proteins in human soft tissue sarcomas.
Yoo J; Park S; Kang CS; Kang SJ; Kim BK
Arch Pathol Lab Med; 2002 Jan; 126(1):33-8. PubMed ID: 11800644
[TBL] [Abstract][Full Text] [Related]
2. E-Cadherin Expression and p53 Alterations in Soft Tissue Sarcomas: A Possible Role in Epithelial Differentiation.
Yoo JY; Kang SJ; Ahn WS; Kim BK
Cancer Res Treat; 2001 Aug; 33(4):343-9. PubMed ID: 26680806
[TBL] [Abstract][Full Text] [Related]
3. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
[TBL] [Abstract][Full Text] [Related]
4. Expression of E-cadherin in bone and soft tissue sarcomas: a possible role in epithelial differentiation.
Sato H; Hasegawa T; Abe Y; Sakai H; Hirohashi S
Hum Pathol; 1999 Nov; 30(11):1344-9. PubMed ID: 10571515
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of G1 regulatory proteins in human soft tissue sarcomas.
Yoo J; Park SY; Kang SJ; Shim SI; Kim BK
Arch Pathol Lab Med; 2002 May; 126(5):567-73. PubMed ID: 11958662
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
[TBL] [Abstract][Full Text] [Related]
7. Expression of cadherins, p53, and BCL2 in small cell carcinomas of the cervix: potential tumor suppressor role for N-cadherin.
Zarka TA; Han AC; Edelson MI; Rosenblum NG
Int J Gynecol Cancer; 2003; 13(2):240-3. PubMed ID: 12657131
[TBL] [Abstract][Full Text] [Related]
8. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia.
Creager AJ; Cohen JA; Geradts J
Cancer Detect Prev; 2001; 25(2):123-31. PubMed ID: 11341347
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity of p53, Mdm2, p21(WAF1/CIP1) Bcl-2, and Bax in soft tissue sarcomas: correlation with histologic grade.
Sabah M; Cummins R; Leader M; Kay E
Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):64-9. PubMed ID: 17536310
[TBL] [Abstract][Full Text] [Related]
11. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas.
Taubert H; Würl P; Meye A; Berger D; Thamm B; Neumann K; Hinze R; Schmidt H; Rath FW
Cancer; 1995 Oct; 76(7):1187-96. PubMed ID: 8630896
[TBL] [Abstract][Full Text] [Related]
12. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.
Cordon-Cardo C; Latres E; Drobnjak M; Oliva MR; Pollack D; Woodruff JM; Marechal V; Chen J; Brennan MF; Levine AJ
Cancer Res; 1994 Feb; 54(3):794-9. PubMed ID: 8306343
[TBL] [Abstract][Full Text] [Related]
13. Epithelioid sarcoma: presence of vascular-endothelial cadherin and lack of epithelial cadherin.
Smith ME; Brown JI; Fisher C
Histopathology; 1998 Nov; 33(5):425-31. PubMed ID: 9839166
[TBL] [Abstract][Full Text] [Related]
14. p53 status in radiation-induced soft-tissue sarcomas.
Taubert H; Meye A; Bache M; Hinze R; Holzhausen HJ; Schmidt H; Rath FW; Dunst J; Würl P
Strahlenther Onkol; 1998 Aug; 174(8):427-30. PubMed ID: 9739384
[TBL] [Abstract][Full Text] [Related]
15. p53 gene mutations in soft-tissue sarcomas--correlations with p53 immunohistochemistry and DNA ploidy.
Schneider-Stock R; Radig K; Oda Y; Mellin W; Rys J; Niezabitowski A; Roessner A
J Cancer Res Clin Oncol; 1997; 123(4):211-8. PubMed ID: 9177493
[TBL] [Abstract][Full Text] [Related]
16. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
Fricke E; Keller G; Becker I; Rosivatz E; Schott C; Plaschke S; Rudelius M; Hermannstädter C; Busch R; Höfler H; Becker KF; Luber B
Int J Cancer; 2003 Mar; 104(1):60-5. PubMed ID: 12532420
[TBL] [Abstract][Full Text] [Related]
17. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
Stratton MR; Moss S; Warren W; Patterson H; Clark J; Fisher C; Fletcher CD; Ball A; Thomas M; Gusterson BA
Oncogene; 1990 Sep; 5(9):1297-301. PubMed ID: 2216456
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas.
Drobnjak M; Latres E; Pollack D; Karpeh M; Dudas M; Woodruff JM; Brennan MF; Cordon-Cardo C
J Natl Cancer Inst; 1994 Apr; 86(7):549-54. PubMed ID: 8133539
[TBL] [Abstract][Full Text] [Related]
19. Expression of p21WAF1/CIP1 in soft tissue sarcomas: a comparative immunohistochemical study with p53 and Ki-67.
Pindzola JA; Palazzo JP; Kovatich AJ; Tuma B; Nobel M
Pathol Res Pract; 1998; 194(10):685-91. PubMed ID: 9820864
[TBL] [Abstract][Full Text] [Related]
20. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas.
Wadayama B; Toguchida J; Yamaguchi T; Sasaki MS; Yamamuro T
Br J Cancer; 1993 Dec; 68(6):1134-9. PubMed ID: 8260365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
